PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Schizophr Res. Author manuscript; available in PMC May 1, 2012.
Published in final edited form as:
PMCID: PMC3085627
NIHMSID: NIHMS278982
White Matter Integrity and Lack of Insight in Schizophrenia and Schizoaffective Disorder
Daniel Antonius,ab Vasthie Prudent,ab Yasmina Rebani,bc Debra D'Angelo,d Babak A. Ardekani,ae Dolores Malaspina,ab and Matthew J. Hoptmanad
a Department of Psychiatry, New York University School of Medicine, New York, NY
b Institute for Social and Psychiatric Initiatives (InSPIRES), New York University School of Medicine, New York, NY
c Department of Psychology, Long Island University, Brooklyn, NY
d Schizophrenia Research Division, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY
e Center for Advanced Brain Imaging, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY
Correspondence: Daniel Antonius, PhD, New York University School of Medicine, Department of Psychiatry, 500 First Avenue, NBV 22N10, New York, NY 10016, USA, Phone: 212-263-8107, Fax: 212-263-2760, daniel.antonius/at/nyumc.org
Objective
Poor insight into illness is commonly associated with schizophrenia and has implications for the clinical outcome of the disease. A better understanding of the neurobiology of these insight deficits may help the development of new treatments targeting insight. Despite the importance of this issue, the neural correlates of insight deficits in schizophrenia remain poorly understood.
Method
Thirty-six individuals diagnosed with schizophrenia or schizoaffective disorder underwent diffusion tensor imaging (DTI). The subjects were assessed on two dimensions of insight (symptom awareness and attribution of symptoms) using the Scale to Assess Unawareness of Mental Disorder (SUMD). Level of psychosis was assessed with the Positive and Negative Syndrome Scale (PANSS).
Results
White matter abnormalities in the right superior frontal gyrus, left middle frontal gyrus, bilateral parahippocampal gyrus, adjacent to the right caudate head, right thalamus, left insula, left lentiform nucleus, left fusiform gyrus, bilateral posterior cingulate, left anterior cingulate, right cingulate gyrus, left lingual gyrus, and bilateral claustrum were associated with symptom unawareness. Misattribution of symptoms was related to deficits in the white matter adjacent to the right lentiform nucleus, left middle temporal gyrus, and the right precuneus.
Conclusions
Impaired insight in schizophrenia implicates a complex neural circuitry: white matter deficits in fronto-temporo brain regions are linked to symptom unawareness; compromised temporal and parietal white matter regions are involved in the misattribution of symptoms. These findings suggest the multidimensional construct of insight has multiple neural determinants.
Keywords: Diffusion Tensor Imaging, white matter, insight, awareness, frontal lobe, temporal lobe
Insight into illness is widely considered to be an important factor in coping with and treating schizophrenia (Amador & David, 2004). For this reason, there is considerable interest in understanding the underlying neural mechanisms of insight, which may have important implications for the development of future insight-oriented neuropsychiatric treatment. However, although extant research indicates a neurological etiology of insight deficits in schizophrenia (Pia & Tamietto, 2006; Shad et al., 2006b), the specific neural circuitry involved remains poorly understood.
Within clinical psychiatry, insight is commonly considered a multidimensional construct that refers to an individual's awareness of having a mental illness, understanding the need for treatment, awareness of the social consequences of mental disorder, and insight into specific psychopathological symptoms and ability to attribute these symptoms to a mental disorder (Amador et al., 1991, 1993). Diminished insight is associated with severity of psychopathology (Kemp & Lambert, 1995) and is more prevalent in schizophrenia compared to other psychotic disorders (Amador et al., 1994). Moreover, impaired insight poses a problem for adherence to treatment (Buckley et al., 2007; Lacro et al., 2002), prolongs duration of psychosis (Drake et al., 2000), and increases the risk for relapse, re-hospitalization (Drake et al., 2007) and involuntary status in the hospital (Kelly et al., 2004). Conversely, better insight into illness is related to better psychological coping mechanisms (Donohoe et al., 2004; Lysaker et al., 2003), as well as compliance with treatment and improved prognosis (Schwartz et al., 1997).
Early theories on the neurological etiology of insight deficits were partially based on the shared behavioral similarities between insight deficits in schizophrenia and the neurological disorder anosognosia (unawareness of deficits caused by brain injury). These theories focus on frontal, prefrontal (Amador et al., 1991), and right parietal lobe (David, 1990) deficits. More recent theoretical conceptualizations of insight in schizophrenia argue that the deficits are more complex, with various distinct brain areas implicated (David, 1999).
Neuropsychological studies largely support a relationship between poor insight and brain impairment in the frontal (Lysaker et al., 1998; Ritsner & Blumenkrantz, 2007; Young et al., 1993), and prefrontal and parietal lobes (Laroi et al., 2000; McEvoy et al., 1996), although the findings are inconsistent (Arduini et al., 2003; Cuesta & Peralta, 1994; Drake & Lewis, 2003; Freudenreich et al., 2004; Goodman et al., 2005; Kemp & David, 1996). In fact, reviews of neuropsychological studies suggest that the pathogenesis of insight deficits in schizophrenia is associated with impaired functioning in the frontal and parietal lobes, and these insight deficits are similar to impaired insight found in individuals suffering from anosognosia (Pia & Tamietto, 2006; Shad et al., 2006b).
Neuroimaging research provides further evidence for underlying brain impairment in insight deficits in schizophrenia. Brain studies on insight deficits implicate larger ventricular volume, in particular in the third ventricle (Takai et al., 1992), smaller total brain and intracranial size (Flashman et al., 2000), and frontal lobe atrophy (Laroi et al., 2000). Additionally, insight deficits have been associated with smaller right dorsolateral prefrontal cortex (Shad et al., 2006a; Shad et al., 2004), and smaller bilateral middle frontal gyrus, right gyrus rectus, and left anterior cingulate gyrus volumes (Flashman et al., 2001). Imaging research also links insight deficits to reduced gray matter concentration in the left posterior cingulate, right anterior cingulate, bilateral inferior temporal regions including the lateral fusiform gyri (Ha et al., 2004), the right superior frontal gyrus, total inferior frontal gyrus, right orbitofrontal gyrus, and total prefrontal region (Sapara et al., 2007).
Three imaging studies found no significant correlations between lack of insight and total ventricular volume (David et al., 1995), grey and white matter volumes (Bassitt et al., 2007; Rossell et al., 2003), and cerebrospinal fluid and total brain matter volumes (Rossell et al., 2003). In a longitudinal study on insight improvement, one study found that patients with better insight showed increased activation in the left medial prefrontal cortex and right lingual gyrus (Lee et al., 2006). Two imaging studies report on the attribution of the psychiatric symptoms to a mental disorder; misattribution of symptoms were linked to larger right medial orbitofrontal cortex (Shad et al., 2006a) and smaller superior frontal gyrus volumes (Flashman et al., 2001).
Using a voxel-based morphometry approach to specifically examine insight sub-factors and grey matter volumes in patients with schizophrenia or schizoaffective disorder, Cooke et al. (2008) found correlations between: higher awareness of problems and increased regional grey matter volume in the left precuneus; higher symptom re-labeling and greater absolute grey matter in the right superior temporal gyrus; and, better awareness of and attribution to illness and greater regional grey matter in the left superior-middle temporal gyrus, the right inferior temporal gyrus, and the lateral parietal gyri. A fourth sub-factor, the awareness of need for medication, was not found to correlate with grey matter volumes. More recently, Palaniyappan et al. (2010) used high resolution MRI to examine the white matter volume of the posterior insula, specifically, and found that lower surface area and white matter volume of the right posterior insula, but not the left, was related to reduced insight.
Taken together, the neuroimaging and neuropsychological findings support a neurological etiology of insight deficits in schizophrenia (with some similarities to anosognosia). The distribution of impaired brain regions suggests that the insight deficits may be due to a disruption in neural circuitry, as compared to distinct brain region impairment. Thus far, neuroimaging studies on insight in schizophrenia have utilized either computed tomography (David et al., 1995; Laroi et al., 2000), structural magnetic resonance imaging (sMRI; Cooke et al., 2008; Flashman et al., 2000, 2001; Ha et al., 2004; Palaniyappan et al., 2010; Rossell et al., 2003; Sapara et al., 2007; Shad et al., 2006a, 2006b; Takai et al., 1992) or functional MRI (Lee et al., 2006) techniques. To further advance our understanding of the neural circuitry involved in impaired insight in schizophrenia, we employed diffusion tensor imaging (DTI) to study white matter integrity, which provides information on the organization and integrity of white matter.
Participants
Participants were selected from a larger, ongoing neuroimaging study of white matter abnormalities in schizophrenia, which was approved by the Nathan S. Kline Institute for Psychiatric Research/Rockland Psychiatric Center Institutional Review Board and the Rockland County Department of Mental Health Institutional Review Board. All participants provided written informed consent prior to participation.
Thirty-six patients were included in the analysis. Demographic information is presented in Table 1. All patients met DSM-IV diagnostic criteria for schizophrenia (n=32) or schizoaffective disorder (n=4) as confirmed by the Structured Clinical Interview for DSM-IV Axis I Disorders – Patient Edition (First et al., 1998). Patients were excluded if they met SCID-I/P criteria for substance dependence (lifetime), or substance abuse within the six months prior to study enrollment. Patients with neurological disorders or history of head trauma with loss of consciousness greater than 15 minutes were also excluded.
Table 1
Table 1
Demographic and clinical information.
Procedure
Clinical Ratings
Insight into illness was measured using the Scale to Assess Unawareness of Mental Disorders (SUMD; Amador & Strauss, 1990). The SUMD is a twenty-item scale used to assess a patient's insight based on three dimensions: 1) general awareness of mental illness (including awareness of his or her current and past mental disorder, achieved effects of medication, and social consequences of mental disorder); 2) awareness of psychiatric symptoms, and; 3) attribution of symptoms, which refers to the degree to which he or she attributes the psychiatric symptoms to mental illness. Each item is rated on a Likert-type scale from 0 to 5. General and symptom awareness are rated using the following anchor points: 0=Cannot be assessed/item not relevant, 1=Aware (subject believes that he or she is mentally ill and suffers from psychiatric symptoms), 3=Somewhat (unsure, but can entertain the idea of mental illness/psychiatric symptoms), and 5=Unaware (does not believe he or she suffers from a mental illness or psychiatric symptoms). Attribution of symptoms are rated: 0=Cannot be assessed/item not relevant, 1=Correct (symptom is related to mental disorder), 3=Partial (considers possibility that symptom is due to mental disorder), and 5=Incorrect (believes symptom is not related to mental disorder). For the purpose of this study, we focused on current symptoms only and a mean score was calculated and used for analyses. Following traditional scoring of the SUMD (Amador & Strauss, 1990), we did not use weighted scores. Also, because the general items assess different dimensions of insight function, which may complicate interpretations, we focused (similarly to other studies; e.g., Shad et al., 2006) only on awareness of psychiatric symptoms and attribution of symptoms1.
Current psychiatric symptomatology was assessed with the Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987), which consists of thirty items rated from 1 (absence of psychopathology) to 7 (severe psychopathology). The scale is divided into positive, negative, and general items. Because the SUMD addresses symptoms that are also included on the PANSS, both scales were administered during the same session. SUMD items were only rated if the symptom was rated as present on the PANSS. Both scales were administered by trained study personnel.
Neuroimaging
Scanning was performed on a 1.5T Siemens Vision System (Erlangen, Germany) at the Center for Advanced Brain Imaging at the Nathan Kline Institute. Patients received an inversion-prepared T1-weighted scan (TR=11.6ms, TE=4.9ms, TI=1122ms, matrix=256×256, FOV=320mm, NEX=1, slice thickness = 1 mm, 190 slices, no gap), as well as a turbo dual spin echo scan (TR=ms, TE=22/90ms, matrix=256×256, FOV=240mm, slice thickness = 5mm, 26 slices, no gap), and a DTI scan (TR=6000ms, TE=100ms, matrix=128×128, FOV=300mm, NEX=7, slice thickness = 5mm, 19 slices, no gap) acquired in an oblique axial plane parallel to the anterior commissure – posterior commissure line. The b value for the DTI scan was 1000 s2/mm. Eight noncollinear diffusion sensitization directions were used (Jones et al., 1999).
Postprocessing
Fractional anisotropy (FA) was calculated using software written by one of the authors (BAA). The FA images were transformed into Talairach space using methods described elsewhere (Ardekani et al., 2003). The b=0 images were corrected for susceptibility induced distortion and were transformed into MNI space using methods described elsewhere (Ardekani et al., 2003; Hoptman et al., 2004). Images were matched to a template in MNI space, and the final voxel size was 1×1×1mm3. A white matter mask was computed from the mean spatially normalized patient FA image using a nonparametric image segmentation algorithm (Otsu, 1979) and was applied to all of the standardized images. This approach limited the voxels to white matter and resulted in fewer statistical comparisons, thereby lowering the probability of false positive tests.
Data Analysis
Because FA is negatively correlated with age (Pfefferbaum et al., 2000; Salat et al., 2005), we computed partial correlations on a voxelwise basis, controlling for age. Partial correlations were tested for significance using t-tests. We converted our t-maps and corresponding degrees of freedom maps to p-maps using custom software. From the p-maps we computed the p-value (corresponding to p = .0036 for Symptom Misattribution and p = .0041 for Symptom Unawareness) that would yield a false discovery rate (FDR) of 5% using FSL's fdr program. To further protect against Type-I error, we selected a minimum cluster size of 50 voxels (50 mm3). The thresholded correlation maps were superimposed onto the T1-weighted template using AFNI software (Cox, 1996).
Correlations between Clinical Variables
Pearson bivariate correlations were conducted to investigate associations between SUMD and PANSS variables (descriptive information on the clinical variables is presented in Table 1). A significant relationship emerged between the PANSS insight item “Judgment and Insight” and the SUMD subscales (symptom awareness: r = 0.65; attribution: r = 0.74; both p < 0.01), suggesting convergent validity. The analyses also revealed a significant relationship between the PANSS total score, when controlled for the insight item “Judgment and Insight” (excluded from the analyses), and SUMD symptom awareness, r = 0.37, p < 0.05, indicating that subjects with higher levels of overall psychosis symptoms exhibited poorer insight. A marginal relationship emerged between the PANSS total score, controlled for the PANSS insight item, and SUMD attribution, r = 0.30, p = 0.10. PANSS positive symptoms subscale correlated significantly with both SUMD subscales (symptom awareness: r = 0.50; and attribution: r = 0.74; both p < 0.01), suggesting that psychosis symptoms such as delusions and hallucinations may play a particularly important role in insight deficits. No correlations were revealed between PANSS negative/general subscales and the SUMD subscales.
Chi-square statistics revealed no significant gender and ethnicity differences for PANSS total and subscale scores and SUMD subscale scores.
Neuroimaging Correlations
The neuroimaging results revealed significant correlations between fractional anisotropy (FA) values and the SUMD symptom unawareness and misattribution of symptoms in multiple regions. These data are presented in Table 2 and and3,3, and Figures 1 and and22.
Table 2
Table 2
Location of significant correlations between fractional anisotropy and awareness of symptoms (SUMD Items 4-20).
Table 3
Table 3
Location of significant correlations between fractional anisotropy and attribution of symptoms (SUMD Items 4b-20b).
Figure 1
Figure 1
Sagital view of fractional anisotropy and awareness of symptoms (SUMD Items 4-20).
Figure 2
Figure 2
Sagital view of fractional anisotropy and attribution of symptoms (SUMD Items 4b-20b).
The present study utilized DTI to investigate the brain regions involved in insight deficits in individuals diagnosed with schizophrenia or schizoaffective disorder. Using a multidimensional classification of insight our findings suggest that white matter deficits in fronto-temporo brain regions are linked to symptom unawareness, and reduced white matter integrity in temporal and parietal regions is involved in the misattribution of symptoms.
Symptom Unawareness
Our imaging results for symptom unawareness implicate a complex network of fronto-temporal brain regions. Many of the regions are also involved in memory, cognitive, and emotional processing, suggesting a possible complex interplay between impairment in these areas and insight into specific psychiatric symptoms. Given the range of factors covered under symptom unawareness, including positive (e.g. delusions, hallucinations), negative (e.g. alogia, flat affect), cognitive (e.g. poor attention, confusion/disorientation), and other behavioral symptoms (e.g. poor control of aggressive and sexual impulses), a complex neural network is not unexpected.
In our study, the patients with poor insight into their symptoms demonstrated reduced FA in several frontal lobe regions, including the left middle and right superior frontal gyri. This finding is in support of other studies that have found the frontal lobe (Lysaker et al., 1998; Ritsner & Blumenkrantz, 2007; Young et al., 1993), particularly the prefrontal cortex (Sapara et al., 2007; Shad et al., 2004), to be a central brain region for insight in schizophrenia. As frontal lobe abnormalities underlie social cognitive deficits in schizophrenia (Yamada et al., 2009), poor insight might be mediated by cognitive deficiencies (Shad et al., 2006b).
The temporal lobe is also important to symptom awareness. We found reduced white matter integrity in the bilateral parahippocampal gyrus and the left fusiform gyrus in the patients with poor insight into their symptoms. This may suggest that memory processing is a key feature in symptom awareness as the temporal lobe is important for working memory processing (Schon et al., 2009), and the parahippocampus is involved in non-verbal memory for successful decision making (Harrington et al., 2004). This finding supports other research that speculates a connection between poor insight and deficits in executive working memory (Shad et al., 2007). Thus, it is possible that in people with schizophrenia, deficits in temporal lobe regions underlie impaired processing of memories related to psychiatric symptoms and the ability to make decisions about the psychiatric illness.
Furthermore, our findings indicate that symptom unawareness is related to deficits in white matter in or near the cingulate (left/right posterior, left anterior and right cingulate gyrus), the right thalamus, the right caudate head, the left insula, the left/right claustrum, and the left lentiform nucleus. The cingulate connects with the hippocampus and prefrontal cortex and is involved in a variety of cognitive processes such as affective processing, learning and memory. In patients with schizophrenia, several studies have shown that the anterior part of the cingulate is reduced (Baiano et al., 2007), and reports have speculated that the anterior cingulate and other paralimbic structures are important in the pathophysiology of the disease and in the mechanisms of insight (Ha et al., 2004; Shad et al., 2007).
The caudate and the lentiform nucleus are part of the basal ganglia, which projects to the prefrontal cortex and is in involved in executive functions, learning and memory (Graybiel, 1995). As the basal ganglia is connected to the medial temporal lobe (Packard & Knowlton, 2002), deficits in the caudate and lentiform nucleus regions may add to the impaired memory processing that negatively affects insight into psychiatric symptoms. The basal ganglia is also connected to the thalamus, which is considered to be a relay station for sensory processes, but also believed to be a central region implicated in attention and consciousness (Newman, 1995). The thalamus may therefore be important in relaying physiological and psychological changes to the frontal cortex, while reduced white matter integrity surrounding the thalamus may impair the connectivity between the thalamus and the frontal cortex thus compromising awareness of psychiatric symptoms.
Because of the complexity of examining the combined awareness of various different psychopathological symptoms that potentially have distinct neurological underpinnings, the data should be interpreted with some caution. Future research studies designed specifically to examine the neural correlates of the individual psychopathological symptoms will help to clarify the neural pathways involved in insight deficits and further advance the field.
Symptom Misattribution
The ability to attribute psychiatric symptoms to mental illness requires some level of awareness (Shad et al., 2007). However, as our findings and those of others (Flashman et al., 2001; Shad et al., 2006a) suggest, there appear to be different neuroanatomical bases for symptom awareness and symptom attribution. In contrast to other studies (Flashman et al., 2001; Shad et al., 2006a), we did not find symptom misattribution to be related to frontal lobe impairment. Instead, our findings implicate lower FA in white matter near the right precuneus, the right lentiform nucleus, and the left middle temporal gyrus.
The precuneus is located in the parietal lobe and research suggests its involvement in self-consciousness (Cavanna & Trimble, 2006). Being conscious of one's self is expectedly important for initial evaluation of any changes in mental state to then subsequently search for attributable factors for those changes. In schizophrenia, hypoactivation in the precuneus has been related to poor procedural learning (Kumari et al., 2002). The middle temporal gyrus and the lentiform nucleus (as previously discussed, part of the basal ganglia) are both involved in memory processing. The involvement of temporal lobe regions in misattribution of psychiatric symptoms suggests that memory and recognition of psychiatric symptoms are important aspects of successful attribution of symptoms; an individual with schizophrenia must be able to compare and process memory of their past health to their current illness in order to identify the factors that are responsible for illness severity. Although we did not find direct evidence of frontal involvement, it should be added that some of the white matter regions in which we found correlations are in pathways that may include frontal projections. A tractography approach, in which the pathways that pass through these regions could be visualized, would be particularly useful in this regard.
Positive Correlations
We found that higher FA values was associated with higher awareness of symptoms in the left supramarginal gyrus, left/right inferior parietal lobule, right middle frontal gyrus, left subthalamic nucleus, and right culmen. These results suggest greater white matter integrity in these regions was related to reduced insight. This finding was unexpected and difficult to explain, possibly due to methodological limitations. One possible explanation is that increased FA may represent loss of crossing fibers, thus resulting in less complex neuronal networks. We may also surmise that with the various regions of the brain having the same process of neuronal deterioration, some areas present more parallel distribution and thus reduced complexity. Another explanation may be that the positive correlations are due to the complexity of insight. Future studies specifically examining the positive correlations between insight deficits and FA are needed.
Limitations
There are several limitations with this study that bear discussion. We included both patients with schizophrenia and schizoaffective disorder in the study. As both disorders are heterogeneous, future studies should examine insight deficits in more homogeneous schizophrenia groups. Also, future imaging studies may want to compare insight into illness to self-reflective abilities (i.e., metacognition) as research shows that poor insight is closely related to impaired self-awareness (Koren et al., 2004; Lysaker et al., 2005), and recent fMRI research has begun to identify the neural circuitry for impaired awareness of self (and others) in schizophrenia (Murphy et al., 2010). Additionally, all our subjects were chronic schizophrenia patients at a state psychiatric hospital, which may suggest more severe psychotic symptoms and poorer insight than what is typically found in outpatients. This may have confounded the results, and it is important that future DTI research also examines groups (e.g., outpatients) with lower levels of symptoms. Although all our subjects were on antipsychotic medication, we did not analyze medication effects on insight ratings and imaging processing. To fully examine the role of medication effects on the neurobiology of insight, one will need to enroll first-episode or early-course schizophrenia patients. Similar to other imaging studies examining brain white matter and insight in schizophrenia (e.g., Palaniyappan et al., 2010) we did not include a healthy comparison group, thus limiting conclusive interpretations of the specificity of our imaging findings. Images were acquired on a 1.5 Tesla scanner and had a 5 mm slice thickness, and at the time the study took place our DTI scans had a very high signal-to-noise ratio (SNR). However, thinner slices can now be collected at higher field strength to optimize SNR and resolution in DTI protocols.
Conclusions
Having insight into one's own illness and understanding of the consequences of the disease and need for treatment is an important part of a successful prognosis in people with schizophrenia. Neuroimaging and neuropsychological research suggest a neurological etiology of insight deficits, which may have implications for treatment. We used DTI to examine white matter integrity and its correlation with insight into illness in people with schizophrenia. We found that poor awareness of psychiatric symptoms was linked to compromised white matter integrity in various fronto-temporo brain regions. Misattribution of symptoms was related to reduced FA in parietal and temporal brain regions. These findings indicate that impaired insight in schizophrenia implicates a complex neural circuitry, which involves various cognitive and memory systems.
Acknowledgments
The authors would like to thank Raj Sangoi (RT)(R)(MR) for technical assistance in collecting imaging data.
Funding sources: This work was supported by R01 MH064783 and R21 MH084031 to MJH. The funding sources had no role in study design; in the collection, analysis and interpretation of data; in writing the report; and in the decision to submit the paper for publication.
Footnotes
1Analyses pertaining to the general SUMD items are available upon request.
Conflict of Interest: The authors have no conflicts of interest to report.
Contributors: Drs. Antonius and Hoptman were involved in the design and writing of the study protocol. Ms. Prudent, Rebani, D'Angelo and Drs. Antonius, Ardekani and Hoptman managed literature reviews and statistical analyses pertaining to the study. Ms. Prudent, Rebani, D'Angelo and Drs. Antonius, Ardekani, Malaspina and Hoptman were involved in the writing of various drafts and the final manuscript. All authors contributed to and have approved the final manuscript.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  • Amador XF, David AS, editors. Insight and Psychosis: Awareness of Illness in Schizophrenia and Related Disorders. second. Oxford: Oxford University Press; 2004.
  • Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry. 1994;51(10):826–836. [PubMed]
  • Amador XF, Strauss DH. The scale to assess unawareness of mental disorder. New York: Columbia University and New York Psychiatric Institute; 1990.
  • Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. Assessment of insight in psychosis. Am J Psychiatry. 1993;150(6):873–879. [PubMed]
  • Amador XF, Strauss DH, Yale SA, Gorman JM. Awareness of illness in schizophrenia. Schizophr Bull. 1991;17(1):113–132. [PubMed]
  • Ardekani BA, Nierenberg J, Hoptman MJ, Javitt DC, Lim KO. MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport. 2003;14(16):2025–2029. [PubMed]
  • Arduini L, Kalyvoka A, Stratta P, Rinaldi O, Daneluzzo E, Rossi A. Insight and neuropsychological function in patients with schizophrenia and bipolar disorder with psychotic features. Can J Psychiatry. 2003;48(5):338–341. [PubMed]
  • Baiano M, David A, Versace A, Churchill R, Balestrieri M, Brambilla P. Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies. Schizophr Res. 2007;93(1-3):1–12. [PubMed]
  • Bassitt DP, Neto MR, de Castro CC, Busatto GF. Insight and regional brain volumes in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 2007;257:58–62. [PubMed]
  • Buckley PF, Wirshing DA, Bhushan P, Pierre JM, Resnick SA, Wirshing WC. Lack of insight in schizophrenia: impact on treatment adherence. CNS Drugs. 2007;21(2):129–141. [PubMed]
  • Cavanna AE, Trimble MR. The precuneus: a review of its functional anatomy and behavioural correlates. Brain. 2006;129(3):564–583. [PubMed]
  • Cooke MA, Fannon D, Kuipers E, Peters E, Williams SC, Kumari V. Neurological basis of poor insight in psychosis: A voxel-based MRI study. Schizophr Res. 2008;103(1-3):40–51. [PMC free article] [PubMed]
  • Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 1996;29(3):162–173. [PubMed]
  • Cuesta MJ, Peralta V. Lack of insight in schizophrenia. Schizophr Bull. 1994;20(2):359–366. [PubMed]
  • David A, van Os J, Jones P, Harvey I, Foerster A, Fahy T. Insight and psychotic illness. Cross-sectional and longitudinal associations. Br J Psychiatry. 1995;167(5):621–628. [PubMed]
  • David AS. Insight and psychosis. Br J Psychiatry. 1990;156:798–808. [PubMed]
  • David AS. “To see oursels as others see us”. Aubrey Lewis's insight. Br J Psychiatry. 1999;175:210–216. [PubMed]
  • Donohoe G, Donnell CO, Owens N, O'Callaghan E. Evidence that health attributions and symptom severity predict insight in schizophrenia. J Nerv Ment Dis. 2004;192(9):635–637. [PubMed]
  • Drake RJ, Dunn G, Tarrier N, Bentall RP, Haddock G, Lewis SW. Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. J Clin Psychiatry. 2007;68(1):81–86. [PubMed]
  • Drake RJ, Haley CJ, Akhtar S, Lewis SW. Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry. 2000;177:511–515. [PubMed]
  • Drake RJ, Lewis SW. Insight and neurocognition in schizophrenia. Schizophr Res. 2003;62(1-2):165–173. [PubMed]
  • First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0, 8/98 revision) New York: Biometrics Research Department; 1998.
  • Flashman LA, McAllister TW, Andreasen NC, Saykin AJ. Smaller brain size associated with unawareness of illness in patients with schizophrenia. Am J Psychiatry. 2000;157(7):1167–1169. [PubMed]
  • Flashman LA, McAllister TW, Johnson SC, Rick JH, Green RL, Saykin AJ. Specific frontal lobe subregions correlated with unawareness of illness in schizophrenia: a preliminary study. J Neuropsychiatry Clin Neurosci. 2001;13(2):255–257. [PubMed]
  • Freudenreich O, Deckersbach T, Goff DC. Insight into current symptoms of schizophrenia. Association with frontal cortical function and affect. Acta Psychiatr Scand. 2004;110(1):14–20. [PubMed]
  • Goodman C, Knoll G, Isakov V, Silver H. Insight into illness in schizophrenia. Compr Psychiatry. 2005;46(4):284–290. [PubMed]
  • Graybiel AM. Building action repertoires: memory and learning functions of the basal ganglia. Curr Opin Neurobiol. 1995;5(6):733–741. [PubMed]
  • Ha TH, Youn T, Ha KS, Rho KS, Lee JM, Kim IY, et al. Gray matter abnormalities in paranoid schizophrenia and their clinical correlations. Psychiatry Res. 2004;132(3):251–260. [PubMed]
  • Harrington DL, Boyd LA, Mayer AR, Sheltraw DM, Lee RR, Huang M, et al. Neural representation of interval encoding and decision making. Brain Res Cogn Brain Res. 2004;21(2):193–205. [PubMed]
  • Hoptman MJ, Ardekani BA, Butler PD, Nierenberg J, Javitt DC, Lim KO. DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis. Neuroreport. 2004;15(16):2467–2470. [PMC free article] [PubMed]
  • Jones DK, Horsfield MA, Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med. 1999;42(3):515–525. [PubMed]
  • Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276. [PubMed]
  • Kelly BD, Clarke M, Browne S, McTigue O, Kamali M, Gervin M, et al. Clinical predictors of admission status in first episode schizophrenia. Eur Psychiatry. 2004;19(2):67–71. [PubMed]
  • Kemp R, David A. Psychological predictors of insight and compliance in psychotic patients. Br J Psychiatry. 1996;169(4):444–450. [PubMed]
  • Kemp RA, Lambert TJ. Insight in schizophrenia and its relationship to psychopathology. Schizophr Res. 1995;18(1):21–28. [PubMed]
  • Koren D, Seidman LJ, Poyurovsky M, Goldsmith M, Viksman P, Zichel S, Klein E. The neuropsychological basis of insight in first-episode schizophrenia: a pilot metacognitive study. Schizophrenia Research. 2004;70:195–202. [PubMed]
  • Kumari V, Gray JA, Honey GD, Soni W, Bullmore ET, Williams SC, et al. Procedural learning in schizophrenia: a functional magnetic resonance imaging investigation. Schizophr Res. 2002;57(1):97–107. [PubMed]
  • Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63(10):892–909. [PubMed]
  • Laroi F, Fannemel M, Ronneberg U, Flekkoy K, Opjordsmoen S, Dullerud R, et al. Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests. Psychiatry Res. 2000;100(1):49–58. [PubMed]
  • Lee KH, Brown WH, Egleston PN, Green RD, Farrow TF, Hunter MD, et al. A functional magnetic resonance imaging study of social cognition in schizophrenia during an acute episode and after recovery. Am J Psychiatry. 2006;163(11):1926–1933. [PubMed]
  • Lysaker PH, Bell MD, Bryson G, Kaplan E. Neurocognitive function and insight in schizophrenia: support for an association with impairments in executive function but not with impairments in global function. Acta Psychiatr Scand. 1998;97(4):297–301. [PubMed]
  • Lysaker PH, Bryson GJ, Lancaster RS, Evans JD, Bell MD. Insight in schizophrenia: associations with executive function and coping style. Schizophr Res. 2003;59(1):41–47. [PubMed]
  • Lysaker PH, Carcione A, Dimaggio G, Johannesen JK, Nicolò G, Procacci M, Semerari A. Metacognition amidst narratives of self and illness in schizophrenia: associations with neurocognition, symptoms, insight, and quality of life. Acta Psychiatrica Scandinavica. 2005;112:64–71. [PubMed]
  • McEvoy JP, Hartman M, Gottlieb D, Godwin S, Apperson LJ, Wilson W. Common sense, insight, and neuropsychological test performance in schizophrenia patients. Schizophr Bull. 1996;22(4):635–641. [PubMed]
  • Murphy ER, Brent BK, Benton M, Pruitt P, Diwadkar V, Rajarethinam RP, Keshavan MS. Differential processing of metacognitive evaluation and the neural circuitry of the self and others in schizophrenia: A pilot study. Schizophr Res. 2010;116:252–258. [PubMed]
  • Newman J. Thalamic contributions to attention and consciousness. Conscious Cogn. 1995;4(2):172–193. [PubMed]
  • Otsu N. A threshold selection model from gray-level histograms. Vol. 9. IEEE Trans (SMC); 1979. pp. 63–66.
  • Packard MG, Knowlton BJ. Learning and memory functions of the Basal Ganglia. Annu Rev Neurosci. 2002;25:563–593. [PubMed]
  • Palaniyappan L, Mallikarjun P, Joseph V, Liddle PF. Appreciating symptoms and deficits in schizophrenia: Right posterior insula and poor insight. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Epub ahead of print. [PubMed]
  • Pfefferbaum A, Sullivan EV, Hedehus M, Lim KO, Adalsteinsson E, Moseley M. Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magn Reson Med. 2000;44(2):259–268. [PubMed]
  • Pia L, Tamietto M. Unawareness in schizophrenia: neuropsychological and neuroanatomical findings. Psychiatry Clin Neurosci. 2006;60(5):531–537. [PubMed]
  • Ritsner MS, Blumenkrantz H. Predicting domain-specific insight of schizophrenia patients from symptomatology, multiple neurocognitive functions, and personality related traits. Psychiatry Res. 2007;149(1-3):59–69. [PubMed]
  • Rossell SL, Coakes J, Shapleske J, Woodruff PW, David AS. Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med. 2003;33(1):111–119. [PubMed]
  • Salat DH, Tuch DS, Greve DN, van der Kouwe AJ, Hevelone ND, Zaleta AK, et al. Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiol Aging. 2005;26(8):1215–1227. [PubMed]
  • Sapara A, Cooke M, Fannon D, Francis A, Buchanan RW, Anilkumar AP, et al. Prefrontal cortex and insight in schizophrenia: a volumetric MRI study. Schizophr Res. 2007;89(1-3):22–34. [PubMed]
  • Schon K, Quiroz YT, Hasselmo ME, Stern CE. Greater working memory load results in greater medial temporal activity at retrieval. Cereb Cortex. 2009;19(11):2561–2571. [PMC free article] [PubMed]
  • Schwartz RC, Cohen BN, Grubaugh A. Does insight affect long-term impatient treatment outcome in chronic schizophrenia? Compr Psychiatry. 1997;38(5):283–288. [PubMed]
  • Shad MU, Keshavan MS, Tamminga CA, Cullum CM, David A. Neurobiological underpinnings of insight deficits in schizophrenia. Int Rev Psychiatry. 2007;19(4):437–446. [PubMed]
  • Shad MU, Muddasani S, Keshavan MS. Prefrontal subregions and dimensions of insight in first-episode schizophrenia--a pilot study. Psychiatry Res. 2006;146(1):35–42. [PubMed]
  • Shad MU, Muddasani S, Prasad K, Sweeney JA, Keshavan MS. Insight and prefrontal cortex in first-episode Schizophrenia. Neuroimage. 2004;22(3):1315–1320. [PubMed]
  • Shad MU, Tamminga CA, Cullum M, Haas GL, Keshavan MS. Insight and frontal cortical function in schizophrenia: a review. Schizophr Res. 2006;86(1-3):54–70. [PubMed]
  • Takai A, Uematsu M, Ueki H, Sone K, Kaiya H. Insight and its Related Factors in Chronic Schizophrenia Patients: A Preliminary Study. European Journal of Psychiatry. 1992;6:159–170.
  • Yamada M, Ueda K, Namiki C, Hirao K, Hayashi T, Ohigashi Y, et al. Social cognition in schizophrenia: similarities and differences of emotional perception from patients with focal frontal lesions. Eur Arch Psychiatry Clin Neurosci. 2009;259(4):227–233. [PubMed]
  • Young DA, Davila R, Scher H. Unawareness of illness and neuropsychological performance in chronic schizophrenia. Schizophr Res. 1993;10(2):117–124. [PubMed]